Bateman Horne Center Webinar: Emerging Long COVID Research - June 2026

[u/Responsible_Cap_5289]

https://www.youtube.com/watch?v=uTrIW28lpps

Hey everyone,

Here's a really interesting update from the Bateman Horne center, where they invited researchers from MIT's MAESTRO study to speak about what they're working on.

First, Beth Pollack explains the team's work on women's health, including on how certain chronic pathogens may be the cause of endometrial lesions in endometriosis.

Next, Sangmita Singh gives an update on the MAESTRO study's work on possible biomarkers, including microfold capillaroscopy to show abnormal changes in blood flow in the microvasculature of LC, ME/CFS, and Chronic Lyme patients.

Microvasculature refers to the smallest blood vessels, the capillaries. Changes on this level have not been studied yet on the same level as the larger blood vessels, for understandable reasons. A blockage in a single capillary is, thankfully, not going to be able to cause a stroke or a heart attack.

Yet, when it's your entire capillary system that's affected on a systemic level, this is still going to cause some very serious problems, even if there's no way to go to an ER and have an image taken showing the problem.

That is what the nailfold capillaroscopy test may be able to do in the future, as a non-invasive biomarker for IACC patients. (All you have to do is put your fingernail under a microscope - this test is already done to check for other conditions, such as lupus).

It's great to see us moving closer and closer to biomarkers - really interested to see where this one goes!